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Background: Genetic alterations have been identified in 
melanomas according to different levels of sun exposure. 
Whereas the conventional morphology-based classification 
provides a clue for tumor growth and prognosis, the new 
classification by genetic alterations offers a basis for targeted 
therapy. Objective: The purpose of this study is to demon-
strate the biological behavior of melanoma subtypes and 
compare the two classifications in the Korean population. 
Methods: A retrospective chart review was performed on 
patients found to have malignant melanoma in Severance 
Hospital from 2005 to 2012. Age, sex, location of the tumor, 
histologic subtype, tumor depth, ulceration, lymph node 
invasion, visceral organ metastasis, and overall survival were 
evaluated. Results: Of the 206 cases, the most common type 
was acral melanoma (n=94, 45.6%), followed by nonch-
ronic sun damage-induced melanoma (n=43, 20.9%), and 
mucosal melanoma (n=40, 19.4%). Twenty-one patients 
(10.2%) had the chronic sun-damaged type, whereas eight 
patients (3.9%) had tumors of unknown primary origin. 
Lentigo maligna melanoma was newly classified as the 
chronic sun-damaged type, and acral lentiginous melanoma 
as the acral type. More than half of the superficial spreading 
melanomas were newly grouped as nonchronic sun-dama-
ged melanomas, whereas nodular melanoma was rather 
evenly distributed. Conclusion: The distribution of mela-
nomas was largely similar in both the morphology-based and 
sun exposure-based classifications, and in both classifi-
cations, mucosal melanoma had the worst 5-year survival 
owing to its tumor thickness and advanced stage at the time 
of diagnosis. (Ann Dermatol 26(4) 485∼490, 2014)
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INTRODUCTION
The increasing incidence of melanoma and the difficulty 
to treat this disease has led to many researches in me-
lanoma. Conventionally, cutaneous melanoma has been 
distinguished according to four main types based on mor-
phology and histology1, superficial spreading melanoma 
(SSM), lentigo maligna melanoma (LMM), nodular me-
lanoma (NM), and acral lentiginous melanoma (ALM), by 
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Table 1. Patient demographics and clinicopathological factors
Clinicopathological factor Acral Mucosal CSD Non-CSD UP Total
Patient 94 (45.6).... 40 (19.4).... 21 (10.2).... 43 (20.9).... 08 (3.9)0.0.. 206 (100.0)....
Age (yr) 62 (18∼89) 58 (33∼82) 59 (31∼83) 57 (28∼80) 47 (37∼65) 60 (18∼89)
Gender (male : female) 1 : 1.2 1 : 1.1 1 : 0.3 1 : 1.3 1 : 0.6 1 : 1.03
Thickness (mm) 4.01 5.79 3.03 4.73 NA 4.45
Ulceration, present 30 (31.9) 10 (25.0) 06 (28.5) 11 (25.6) 0 (0)0. 57 (27.7)
Stages 0
  Localized (stage I) 33 (35.1) 11 (27.5) 06 (28.5) 15 (34.9) 0 (0)0. 65 (31.6)
  Localized (stage II) 32 (34.0) 12 (30.0) 09 (42.9) 08 (18.6) 0 (0)0. 61 (29.6)
  Regional (stage III) 20 (21.3) 09 (22.5) 03 (14.3) 12 (27.9) 06 (75.0) 50 (24.3)
  Distant (stage IV) 09 (9.6).. 08 (20.0) 03 (14.3) 08 (18.6) 02 (25.0) 30 (14.6)
WHO classification
  SSM 2 0 3 20 0 25 (12.1)
  LMM 0 0 16 0 0 16 (7.8)0
  ALM 82 0 0 0 0 82 (39.8)
  NM 10 0 2 17 1 30 (14.6)
  MM 0 40 0 0 0 40 (19.4)
  Unclassified 0 0 0 6 7 13 (6.3)0
Values are presented as number (%), median (range), or number only.
CSD: chronic sun-induced damage, UP: unknown primary, NA: not applicable, SSM: superficial spreading melanoma, LMM: lentigo
maligna melanoma, ALM: acral lentiginous melanoma, NM: nodular melanoma, MM: mucosal melanoma.
using the World Health Organization classification2. After 
the skin, melanoma is most likely to arise in the juxta-
cutaneous mucous membranes, such as the oral mucosa, 
nasal sinuses, vagina, and anorectal mucosa3. Mucosal 
melanomas are similar to acral melanomas in histologic 
appearance and aggressiveness, which has led to the use 
of the histologic term mucosal lentiginous melanoma4. 
Mucosal melanoma is another common variant other than 
cutaneous melanoma.
Recently, genetic alterations such as BRAF and KIT mu-
tations have been identified in melanomas according to 
different levels of sun exposure, and a new set of cla-
ssification has been established5. On the basis of the 
anatomic location of the tumor and the degree of ultra-
violet (UV) exposure, melanoma is classified into four 
subtypes: (1) melanomas that occur on skin without 
chronic sun-induced damage (non-CSD); (2) melanomas 
on skin with chronic sun-induced damage (CSD); (3) 
mucosal melanomas; and (4) acral melanomas2,5. Mela-
noma of unknown primary site is a unique entity of 
melanoma that develops in a lymph node, subcutaneous 
tissues, or visceral organ without a primary lesion6.
Whereas the conventional morphology-based classifica-
tion provides a clue for tumor growth and characteristics, 
the new classification by genetic alterations offers a basis 
for targeted therapy, such as with the BRAF inhibitor ve-
murafenib (PLX4032) or the tyrosine kinase inhibitor ima-
tinib (formerly known as STI571)7. 
The purpose of this study is to compare the distribution of 
the subtypes according to both classifications and demon-




We retrospectively analyzed the clinical records of 206 
patients who had been found to have and were treated for 
malignant melanoma in Severance Hospital (Seoul, Korea) 
between 2005 and 2012. The study protocol was appro-
ved by the institutional review board of Yonsei University, 
Severance Hospital (IRB No. 4-2012-0165). Clinical data 
were available in all cases.
Clinicopathological data
Age, sex, location of the tumor, tumor depth, ulceration, 
lymph node invasion, visceral organ metastasis, treatment 
modality, and overall survival (OS) were evaluated. Tumor 
thickness was measured according to Breslow thickness, 
and OS was defined as the time from the day of diagnosis 
to the date of death from any cause. Melanomas were 
classified by using both the classification that was based 
on the morphology of the tumor and that suggested by 
Curtin et al.5 in 2005 according to the level of sun 
exposure.
The staging was determined according to the American 
Joint Committee on Cancer (AJCC) guidelines for melano-
ma at the time of diagnosis8. The AJCC Melanoma Staging 
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Database divides melanoma into four stages: localized 
melanoma (stages I and II), regional metastatic melanoma 
(stage III), and distant metastatic melanoma (stage IV).
Statistical analysis
All statistical analyses were performed by using PASW 
Statistics 18.0 (IBM Co., Armonk, NY, USA) and MedCalc 
ver. 12.7.4 (MedCalc Software bvba, Ostend, Belgium). 
Categorical data were described by using numbers and 
percentages. The 5-year survival and OS of the patients 
were estimated by using the Kaplan-Meier method, and 
compared by using the log-rank test. All tests were two- 
sided, and a p-value of ＜0.05 was considered statistically 
significant.
RESULTS
Melanoma subtypes in the Korean population
Of the 206 cases, the most common type was acral me-
lanoma (n=94, 45.6%) followed by the non-CSD type 
(n=43, 20.9%) and mucosal melanoma (n=40, 19.4%). 
Twenty-one patients (10.2%) had the CSD type, whereas 
eight patients (3.9%) had tumors of unknown primary 
origin (Table 1, Fig. 1). The unknown primary origin type 
was diagnosed in patients who had an initial presentation 
of melanoma in the lymph nodes, subcutaneous tissue, or 
visceral organ without a known primary site6.
The median age of patients with the acral type was 62 
years (range, 18∼89 years), ranking as the oldest median 
age among the subtypes, whereas patients with tumors of 
unknown primary origin had the youngest median age of 
47 years. The other subtypes showed no significant diffe-
rences. The male-to-female ratio of the total included pa-
tients was 1 : 1.03. The ratio was increased more than 
threefold in the CSD type, whereas the other types did not 
show such a gap (Table 1).
The mucosal type was the thickest subtype (thickness, 
5.79 mm), followed by the non-CSD type (4.73 mm), acral 
type (4.01 mm), and CSD type (3.03 mm). With the 
classification based on the morphology and histology, NM 
showed a Breslow thickness of 6.86 mm, ALM 3.34 mm, 
LMM 2.84 mm, and SSM 1.72 mm.
In the CSD type, 71.4% of the patients had localized 
melanoma (stages I and II), whereas in the non-CSD and 
mucosal types, localized melanoma was seen less fre-
quently (53.5% and 57.5% of the patients, respectively) 
Fig. 1. (A) Melanoma subtypes based on morpho-
logy and histology. (B) Melanoma subtypes based 
on the level of ultraviolet (UV) exposure. (C) Pro-
portion of conventional histologic subtypes in the 
UV exposure-based classification. SSM: superficial 
spreading melanoma, LMM: lentigo maligna mela-
noma, ALM: acral lentiginous melanoma, NM: no-
dular melanoma, MM: mucosal melanoma, CSD: 
chronic sun-induced damage, UP: unknown primary. 
HS Jang, et al
488 Ann Dermatol
Table 3. Treatment modality of the melanoma patients
Treatement modality Patient (n)
Surgery 197/206
 Wide excision 161/197
 Amputation 031/197
 Mohs micrographic surgery 002/197
 Partial excision 003/197
High dose interferon alpha 032/206
Chemotherapy 046/206
Radiotherapy 031/206
Table 2. Anatomaic location of mucosal melanoma and mela-
noma of unknown primary origin
Location Subtype Patient (n)
Oral cavity Mucosal 16/40
Nasal cavity Mucosal 12/40
Gastrointestinal tract Mucosal 08/40
Genital mucosa Mucosal 04/40
Lymph node UP 05/80
Subcutaneous tissue UP 01/80
Visceral organ UP 02/80
UP: melanoma of unknown primary origin.
Fig. 2. (A) Five-year survival curve of subtypes according to morphology-based classification. (B) Five-year survival curve of subtypes 
according to ultraviolet (UV) exposure-based classification. SSM: superficial spreading melanoma, LMM: lentigo maligna melanoma, 
ALM: acral lentiginous melanoma, NM: nodular melanoma, MM: mucosal melanoma, CSD: chronic sun-induced damage.
(Table 1).
Anatomic location of mucosal melanoma and mela-
noma of unknown primary origin
Among the 40 cases of mucosal melanoma, 16 were 
melanoma arising from the oral cavity, such as the buccal 
mucosa and gingiva, whereas 12 were melanoma arising 
from the nasal cavity, such as the nasal mucosa or naso-
pharynx. Eight patients had melanoma from the gas-
trointestinal tract (esophagus, stomach, small bowel, and 
rectum), and four patients had melanoma from the genital 
mucosa (vagina and vulva) (Table 2). 
Of the eight cases of melanoma from unknown origin, five 
cases were arising from a lymph node, one arising from 
the subcutaneous tissue of the trunk, and two were from a 
visceral organ such as the spine and the brain (Table 2). 
Comparison of the two classifications
All of the LMM cases were newly classified as the CSD 
type, and all of the ALM cases were classified into the 
acral type. Of the SSMs, 80.0% (20 of 25) were newly 
grouped as the non-CSD type. However, NM seemed to 
be rather evenly distributed. Among the 30 NM patients, 
17 patients (56.7%) were grouped into the non-CSD type, 
10 patients (33.3%) into the acral type, 2 patients (6.7%) 
into the CSD type, and 1 patient (3.3%) into the unknown 
primary origin type (Table 1). The unclassified types in-
clude melanomas such as desmoplastic melanoma and 
spitzoid melanoma, and these unclassified types were 
reclassified into the non-CSD type (n=6, 46.1%) and the 
unknown primary type (n=7, 53.8%) (Table 1, Fig. 1).
Melanoma treatment
Most of the patients found to have malignant melanoma 
received operation in variable manners. Excluding 9 pa-
tients who were unable to undergo surgery owing to their 
poor general condition, 197 patients (95.6%) received sur-
gery under general anesthesia. Most of the patients (n= 
161, 78.1%) underwent wide excision, whereas ampu-
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tation was done in 31 patients (15.0%). Two patients with 
LMM had Mohs micrographic surgery, and three patients 
had partial excision of the melanoma but not complete 
excision owing to the metastatic site, such as the spine or 
chest wall (Table 3).
In addition to surgery, 32 patients had high-dose inter-
feron-α treatment, 46 patients had a chemotherapy regi-
men of dacarbazine, and 31 patients with metastasis in 
such sites as the spine or head and neck received radio-
therapy (Table 3). Many patients received a combination 
of more than one systemic therapy. As this study was a 
retrospective study in which the patients were enrolled 
between 2005 and 2012 and followed until 2012 De-
cember, no patients were treated with targeted therapy 
such as the BRAF inhibitor vemurafenib. 
Survival of the subtypes in Korean population
Concerning patient survival, mucosal melanoma had the 
worst 5-year survival in both classifications (p＜0.05), 
owing to its tumor thickness and advanced stage at the 
time of diagnosis (Fig. 2). The median survival of the total 
enrolled patients was 61 months, whereas mucosal me-
lanoma patients had the shortest median survival of 34 
months. Mucosal melanoma had a hazard ratio of 2.07 
(95% confidence interval [CI], 1.12∼3.82) compared with 
acral melanoma, and a hazard ratio of 2.25 (95% CI, 1.12∼ 
4.53) compared with non-CSD melanoma. In the mor-
phology-based classification, mucosal melanoma had a 
hazard ratio of 2.23 (95% CI, 1.09∼4.84) compared with 
SSM, and a hazard ratio of 2.12 (95% CI, 1.15∼3.89) 
compared with ALM.
DISCUSSION
The incidence of melanoma has increased significantly 
worldwide during the last several decades. As the classic 
consensus for diagnosing melanoma is based on histopa-
thologic evaluation of biopsy specimens1, melanoma has 
been classified according to the morphological and archi-
tectural features of the tumor2. 
In Caucasian data, SSM is the most common subtype, ac-
counting for approximately 70% of all cutaneous melano-
mas9. However, in Asians, ALM is the most common type, 
accounting for roughly 45%∼66%10. Our data (Fig. 1) 
show that ALM has the highest incidence, which is 
consistent with previous data in Korean melanoma 
patients11.
Among the risk factors of melanoma, the most important 
factor is known to be a history of periodic and intense sun 
exposure during childhood and adolescence12. Conside-
ring that UV light exposure is an inseparable factor for 
melanoma development, Curtin et al.5 reported in 2005 
that there are distinct sets of genetic alternations in 
melanoma with different susceptibilities to UV exposure.
Curtin et al.5 divided the types according to the level of 
UV exposure: (1) melanomas that occur on skin with non 
chronic sun damage; (2) melanomas on skin with chronic 
sun damage; and melanomas that arise without obvious 
exposure to light, which include (3) mucosal melanomas 
and (4) acral melanomas.
In the Caucasian data of 1,112 cases by Greaves et al.13, 
the non-acral cutaneous type, which refers to the non-CSD 
and CSD types, constituted 69.6%, whereas the acral type 
constituted only 10%. In the Chinese data of 502 cases re-
presenting the Asian population, the most prevalent type 
was the acral type (38.4%) followed by the mucosal type 
(33.3%)7. There is a noticeable difference in the propor-
tion of melanoma subtypes in Caucasian and Asian popu-
lations, and the finding of our study was consistent with 
the Chinese data (Fig. 1).
The single most important prognostic factor for survival in 
localized melanoma is tumor thickness, measured from 
the top of the granular layer to the greatest depth of tumor 
invasion14. It is well known that NM often lacks a radial 
growth phase and thus presents with rapid evolution15; 
consistent with these facts, NM had the thickest Breslow 
thickness (6.86 mm) in our study. Although mucosal mela-
noma had a Breslow thickness of 5.79 mm, it had a grea-
ter proportion of advanced-staged tumors (stage 3 and 
stage 4: 42.5%) than NM (stage 3 and stage 4: 36.5%) and 
showed the worst prognosis among the subtypes in the 
morphology-based classification and also in the UV expo-
sure-based classification. 
In summary, this study reveals that the two classifications 
share many cases in common, such as cases of ALM with 
the acral type and LMM with the CSD type. On the basis 
of the tumor-node-metastases (TNM) stage, mucosal mela-
noma was associated with poor prognosis in Korean 
melanoma patients.
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